Integer Holdings Corporation $ITGR Shares Sold by Amundi

Key Points

• Amundi has reduced its stake in Integer Holdings Corporation by 19.4%, now holding 14,000 shares valued at approximately $1.625 million.
• Several institutional investors have increased their investments in Integer, with Paradigm Capital Management increasing its holdings by 426.2%, now owning 22,100 shares valued at around $2.608 million.
• Analysts are generally optimistic, with the stock receiving multiple upgrades, including a strong-buy rating from Citigroup, and a consensus target price of $140.25.

Amundi decreased its position in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 19.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,000 shares of the medical equipment provider's stock after selling 3,372 shares during the quarter. Amundi's holdings in Integer were worth $1,625,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Congress Asset Management Co. raised its holdings in Integer by 4.9% in the first quarter. Congress Asset Management Co. now owns 522,656 shares of the medical equipment provider's stock valued at $61,679,000 after acquiring an additional 24,306 shares in the last quarter. Cooke & Bieler LP raised its holdings in Integer by 6.3% in the first quarter. Cooke & Bieler LP now owns 317,393 shares of the medical equipment provider's stock valued at $37,456,000 after acquiring an additional 18,790 shares in the last quarter. Raymond James Financial Inc. raised its holdings in Integer by 6.9% in the first quarter. Raymond James Financial Inc. now owns 307,141 shares of the medical equipment provider's stock valued at $36,245,000 after acquiring an additional 19,839 shares in the last quarter. Vaughan Nelson Investment Management L.P. acquired a new stake in Integer in the first quarter valued at approximately $33,337,000. Finally, New York State Common Retirement Fund raised its holdings in Integer by 7.4% in the first quarter. New York State Common Retirement Fund now owns 249,847 shares of the medical equipment provider's stock valued at $29,484,000 after acquiring an additional 17,278 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Performance

Shares of ITGR traded up $1.44 during mid-day trading on Thursday, reaching $104.13. 394,628 shares of the company's stock were exchanged, compared to its average volume of 347,018. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.41 and a quick ratio of 2.18. The stock has a market capitalization of $3.65 billion, a PE ratio of 45.87, a price-to-earnings-growth ratio of 0.81 and a beta of 1.03. The business's fifty day simple moving average is $108.18 and its 200-day simple moving average is $115.38. Integer Holdings Corporation has a 52-week low of $99.73 and a 52-week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a return on equity of 12.27% and a net margin of 4.61%.The company had revenue of $476.00 million for the quarter, compared to analyst estimates of $464.37 million. During the same period in the prior year, the business earned $1.30 earnings per share. Integer's revenue for the quarter was up 11.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, equities research analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have commented on ITGR shares. Wells Fargo & Company dropped their price target on shares of Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. Wall Street Zen upgraded shares of Integer from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. Raymond James Financial dropped their price target on shares of Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research note on Friday, July 25th. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and increased their price target for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Finally, Truist Financial dropped their price target on shares of Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research note on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $140.25.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.